Biotech grants in Singapore
Explore Biotech grants for companies in Singapore. This list brings together funding for drug discovery, diagnostics, cell and gene therapy, biomanufacturing and life-science research from Singaporean innovation agencies, research funders and foundations, international programs open to applicants in Singapore, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Biotech in Singapore come first.
Showing 49-72 of 362 grants
Ethical, Legal and Social Implications (ELSI) Research
NIH · United States
Funds a full research project on the ethics, law and social effects of human genetics — and refuses to review an application with no diverse-perspectives plan.
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD)
NIH · United States
Funds one bundled run from first-in-human through phase 2a for a dementia drug that works on something other than amyloid or tau.
Lupus Insight Prize
LRA · United States
Provides prize recognizing a specific significant recent lupus research discovery through the Lupus Insight Prize.
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21)
NIH · United States
Funds the exploratory version of the same theory-and-methods work on complex trait variation, for ideas that need testing before a larger project is justified.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01)
NIH · United States
Funds work on how GLP-1 and related drugs change cancer risk — raising it for some cancers, lowering it for others.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21)
NIH · United States
Funds smaller, higher-risk work on how GLP-1 and related drugs change cancer risk. No clinical trial in this version.
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis
NIH · United States
Funds a Phase 0, I or II cancer trial that the investigator designed, inside one of six named National Cancer Institute programme areas.
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders
NIH · United States
Funds Phase I trials for heart, lung, blood and sleep disorders — and pays for the final preclinical work needed to start one.
Minor Use Minor Species Development of Drugs
FDA · United States
Funds the safety and effectiveness testing costs of getting a designated new animal drug through FDA approval.
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain
NIH · United States
Funds new genetic or non-genetic tools that deliver genes, proteins or chemicals to specific brain cells or circuits, with validation built in.
Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain
BRAIN Initiative · United States
Funds new methods to study brain cells and circuits with tools for deeper neural research.
NIDA Animal Genomics Program
NIH · United States
Funds genomic work in animals on what makes addiction start, escalate, persist and relapse — any kind of genetic variant.
Parkinson's Foundation Postdoctoral Fellowship — Basic Scientists
Parkinson's Foundation · United States
Supports early Parkinson's disease scientists building translational impact by funding postdoctoral research roles.
Parkinson's Foundation Postdoctoral Fellowship — Clinical Neurologists
Parkinson's Foundation · United States
Supports early-career neurologists launching Parkinson's disease research careers through postdoctoral fellowship funding.
Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens
NIH · United States
Funds running new assays on stored blood, serum and DNA from the All of Us Research Program's biobank.
Parkinson's Foundation Impact Awards
Parkinson's Foundation · United States
Funds independent Parkinson's disease investigators pursuing bold, high-risk projects with translational clinical relevance.
Discovery of in vivo Chemical Probes for the Nervous System
NIH · United States
Funds optimizing an already-validated hit compound into an in vivo chemical probe for a novel brain target.
High Priority HIV and Substance Use Research (R01)
NIH · United States
Funds research where HIV and drug use intersect. Preliminary data are compulsory, and the work must sit on NIH's published HIV priorities.
Opportunities for Collaborative Research at the NIH Clinical Center
NIH · United States
Funds a translational research project run jointly with NIH's own intramural investigators at the Clinical Center, up to $500,000.
Cutting-Edge Basic Research Awards (CEBRA)
NIH · United States
Funds high-risk addiction research that is sparse or absent from the institute's current portfolio — a revolutionary method, or a hypothesis with no precedent.
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System
NIH · United States
Funds a biologic for a nervous system disorder from lead optimisation to phase I, with NIH-paid manufacturing and tox work — and the applicant keeps the IP.
Integrating Biospecimen Science Approaches into Clinical Assay Development
NIH · United States
Funds research into how preanalytical handling of biopsies and other biospecimens distorts biomarker results used in clinical assays.
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research
NIH · United States
Funds research using a screening trial's biorepository — serial blood samples collected before diagnosis, with decades of matched participant data.
NIDCD Research Grants for Translating Basic Research into Clinical Practice
NIH · United States
Funds translational research turning basic findings into clinical tools for communication disorders, with practical clinical impact required.